Bahng MY

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase-4 inhibitor, evogliptin (DA-1229) - Oh_2017_Diabetes.Obes.Metab_19_294
Author(s) : Oh J , Kim AH , Lee S , Cho H , Kim YS , Bahng MY , Yoon SH , Cho JY , Jang IJ , Yu KS
Ref : Diabetes Obes Metab , 19 :294 , 2017
Abstract : Oh_2017_Diabetes.Obes.Metab_19_294
ESTHER : Oh_2017_Diabetes.Obes.Metab_19_294
PubMedSearch : Oh_2017_Diabetes.Obes.Metab_19_294
PubMedID: 27761990

Title : Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers - Gu_2014_Drug.Des.Devel.Ther_8_1709
Author(s) : Gu N , Park MK , Kim TE , Bahng MY , Lim KS , Cho SH , Yoon SH , Cho JY , Jang IJ , Yu KS
Ref : Drug Des Devel Ther , 8 :1709 , 2014
Abstract : Gu_2014_Drug.Des.Devel.Ther_8_1709
ESTHER : Gu_2014_Drug.Des.Devel.Ther_8_1709
PubMedSearch : Gu_2014_Drug.Des.Devel.Ther_8_1709
PubMedID: 25336915